3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
Novel compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
06.08.2003
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Novel compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed. |
---|---|
AbstractList | Novel compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed. |
Author | K.W. FOWLER J. ODINGO |
Author_xml | – fullname: K.W. FOWLER – fullname: J. ODINGO |
BookMark | eNqFyr0KwjAUhuEMOvh3DeYGMmg6dC1FcVEE3UtMvpIDIQk5oVCvXgd3h5dneddiEVPESjy0qp7MOwXVqDmoPOeSAjmKkA6FJlNpAkvDsrveFWdYGsnK7BN_cwSuKIYhKXp6UU2Ft2I5msDY_dyI_fn07C8KOQ3gbCwi6tDfDo1u2qPu9P_jA62yOaA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | CN1434823A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN1434823A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:20:07 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN1434823A3 |
Notes | Application Number: CN20008019121 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030806&DB=EPODOC&CC=CN&NR=1434823A |
ParticipantIDs | epo_espacenet_CN1434823A |
PublicationCentury | 2000 |
PublicationDate | 20030806 |
PublicationDateYYYYMMDD | 2003-08-06 |
PublicationDate_xml | – month: 08 year: 2003 text: 20030806 day: 06 |
PublicationDecade | 2000 |
PublicationYear | 2003 |
RelatedCompanies | ICOS CORP |
RelatedCompanies_xml | – name: ICOS CORP |
Score | 2.581552 |
Snippet | Novel compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030806&DB=EPODOC&locale=&CC=CN&NR=1434823A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fS8MwED7mFPVNpzJ_90H6FtzWrqwPRbZ0ZQjthk7Z20jXlBZGW2xV9K_3Lqzqyx4CIYGQhLvcJfm-O4C7MEYh6YSCdSNhMDOmRO54t2Wia6IA4WG4ksR39gNr8mI-LvqLBiQ1F0bFCf1UwRFRo1ao75U6r4u_RyxXYSvL-zDFpvzBmzuuXt-ODXSALN0dOePZ1J1ynXOHB3rw5KBbYA56xnAHdsmJpij749cRcVKK_wbFO4K9GY6VVcfQkFkLDnidd60F-_7muxurG80rT-DZYFWSiu98zUz2tWYFUZXWKVoeqUUoRR8qgHepiVIb-jNGBEoCAWlFkpdYCCtIXONSammWpGFKSXZO4dYbz_mE4eyWvxux5EG9DOMMmlmeyTZotrRFbFidQUSflANpy07PllEciV43ljI8h_a2US62d13CoYKtETjCuoJm9fYur9H8VuGN2rkfMUCMNw |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fS8MwED7mFOebTmX-XB-kb8FtrXV9KLKlG1XXruiUvY10TWlhtMVWRf96L2FVX_YQCAmEJNzlcsn33QFcBREKSSdgpBsyjeiRSOSOvi1hXR0FCA_DJRd8Z9cznBf9YX4zr0FccWFknNBPGRwRNWqJ-l7K8zr_e8SyJbayuA4SbMruxjPLVivvWMMLkKHaQ2vkT-0pVSm1qKd6TxZeC_R-TxtswfYtOoTSUXodCk5K_t-gjPdhx8ex0vIAajxtQoNWedeasOuuv7uxuta84hCeNVLGCfvOVkQnXyuSC6rSKkHLw5UQpehDBvAuFFYoA9cngkApQEBKHmcFFoEVFFzjgitJGidBIpLsHEF7PJpRh-DsFr8bsaBetQztGOpplvIWKCY3WaQZnX4oPin73OSdnsnDKGS9bsR5cAKtTaOcbu5qQ8OZuZPF5N57PIM9CWETQAnjHOrl2zu_QFNcBpdyF38A5OaPIQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=3-thiazol-4-yl-pyprolidine+derivatives+as+AMP-specific+phosphodiesterase+inhibitors&rft.inventor=K.W.+FOWLER&rft.inventor=J.+ODINGO&rft.date=2003-08-06&rft.externalDBID=A&rft.externalDocID=CN1434823A |